Nanoform announced that it has established Nanoform USA Inc., a wholly owned subsidiary in the U.S. This is a natural progression for the company as it continues to increase the impact of its award-winning nanonization technology and expand its major pharma client base in the US. The establishment of Nanoform USA Inc. follows the recent appointment of Sally Langa as Head of U.S. Sales. Sally brings 30 years of valuable commercial experience in Pharma, having held senior positions at Catalent Pharma, Patheon and Halo Pharmaceutical.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.11 EUR | -3.65% | +9.21% | +33.12% |
04-11 | Nanoform Finland to Deliver Nanomedicine Technology to Japan | MT |
04-11 | Nanoform Enters Exclusive Partnership with CBC to Bring Best-In-Class Nanomedicine Technology to Japan | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+33.12% | 195M | |
+48.67% | 56.69B | |
-2.76% | 41B | |
+36.42% | 38.11B | |
-11.22% | 26.89B | |
+9.25% | 25.59B | |
-23.10% | 18.59B | |
+1.88% | 12.39B | |
+26.43% | 11.99B | |
+21.74% | 11.88B |
- Stock Market
- Equities
- NANOFH Stock
- News Nanoform Finland Oyj
- Nanoform Establishes U.S. Subsidiary; Appoints Sally Langa as Head of U.S. Sales